Markus Enzelberger
InvestorPartner at Versant Ventures
Munich, Germany
Writes $100K – $5M checks · typically $1.5M
About
Markus is a Versant partner in Basel who helps launch new companies from the firm's Ridgeline Discovery Engine. A drug discovery and protein engineering expert, he previously served as CSO and management board member of MorphoSys, which he joined in 2002, and holds a Ph.D. from the Technical University of Stuttgart.
Contact· self-published, not guessed
Experience
- Versant VenturesPartnercurrent2020 — presentBasel, Basel, Switzerland
- Versant VenturesEntrepreneur in Residence2020Basel, Basel, Switzerland
- Granite BioBoard Membercurrent2021 — presentBasel, Switzerland
- Serac BiosciencesBoard Membercurrent2023 — present
- Red Ridge BioBoard Membercurrent2024 — presentBasel, Switzerland
- Abdera TherapeuticsBoard Observercurrent2021 — present
- Ridgeline DiscoveryBoard Membercurrent2020 — present
- Cimeio TherapeuticsBoard Membercurrent2020 — present
- SHS CapitalSenior Advisorcurrent2017 — present
- T-knifeBoard Observercurrent2020 — present
- SixPeaks BioBoard Member2023 — 2025Basel, Switzerland
- Matterhorn BiosciencesBoard Member2022 — 2025Basel, Switzerland
- Develco Pharma Schweiz AGAufsichtsratsmitglied2022 — 2024Basel, Switzerland
- Vertical BioscienceBoard Member2020 — 2023Basel
- Vector BioPharmaBoard Member2020 — 2023
- GNA Biosolutions GmbHAufsichtsratsmitglied2018 — 2021Martinsried
- MorphoSys AGCSO2017 — 2020Greater Munich Metropolitan Area
- MorphoSys AGinterim-CSO2017Greater Munich Metropolitan Area
- MorphoSys AGSenior Vice President2002 — 2017Greater Munich Metropolitan Area
- MorphoSys AGVice President2002 — 2012
Skills & more
Pharmaforschung4Biowissenschaften10Biotechnologie13Pharmaindustrie14Molekularbiologie10Technologietransfer7Biochemie4Biopharmazeutika1Immunologie2Arzneimittelentwicklung7BiokatalyseAntikörper2
+8 more
ProteinchemieForschung und EntwicklungTechnology TransferClinical DevelopmentOnkologieBiopharmaceuticalsBiotechnologyTechnologyFrom Markus's professional profile.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Venture Advisor at Intuitive Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures
Frequently asked questions
- Who is Markus Enzelberger?
- Markus is a Versant partner in Basel who helps launch new companies from the firm's Ridgeline Discovery Engine. A drug discovery and protein engineering expert, he previously served as CSO and management board member of MorphoSys, which he joined in 2002, and holds a Ph.D. from the Technical University of Stuttgart.
- Where does Markus Enzelberger work?
- Markus Enzelberger is Partner at Versant Ventures.
- What check size does Markus Enzelberger write?
- Markus Enzelberger typically writes checks of $100K – $5M.
- Where did Markus Enzelberger go to school?
- Markus Enzelberger studied at Caltech (Postdoc, Applied Physics); University of Stuttgart (Promotion, Chemie).
Same school
Also attended Caltech144
Shaun MaguirePartner at Sequoia CapitalDario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordScott BillerInvestor at GV (Google Ventures)Seth LieblichInvestment Team at 8VCWen HsiehFounding Managing Partner at Matter Venture Partners
+ 138 more
Also attended University of Stuttgart33
Samuel GilCEO & General Partner at JME VenturesLourdes Álvarez de ToledoPartner at JME VenturesNapat NantavechsantiPartner, Growth and Finance at Beacon VCTobias JahnPartner at Hitachi VenturesMichael BauerOperating Partner - Energy at ClimacticGiulio BrugnaroVenture Designer at Founders Factory
+ 27 more

































